Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesUrethra and Bladder Transurethral Surgical ProceduresCPT cpt-52287-cystoscopic-intradetrusor-neurolytic-injection-overactive-bladder
    Ask Trek AI about this page

    CPT 52287: Cystoscopic Intravesical Neurolytic Injection for Overactive Bladder

    Medicare pays $376 on average nationally for this procedure.

    CPT code 52287 describes a cystoscopic procedure in which the clinician inspects the bladder, urethra, and ureteric orifices with a cystoscope and then inserts a needle to inject a neurolytic agent into the detrusor (bladder) muscle for treatment of overactive bladder; service type: cystoscopic intravesical therapeutic injection, typical site of service: ambulatory surgery center or hospital outpatient department (procedural cystoscopy setting).

    For related coverage guidance, see recent payer policy updates: Abortion Services, Prolonged Services for Labor Management, Prolonged Services for Labor Management.

    Customize your policy alerts

    Sign up for cpt 52287 policy alerts

    Get alerted when payer policies referencing 52287 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A 68-year-old female with refractory overactive bladder (OAB) refractory to behavioral therapy and oral anticholinergic/beta-3 agonist medications presents for definitive therapy. The patient reports urinary urgency, frequency, and urge incontinence significantly impacting quality of life despite medication trials. After pre-procedure evaluation including history, focused pelvic/urinary exam, urinalysis to exclude infection, and counseling about risks/benefits, the urologist schedules an in-office or ambulatory surgical center procedure.

    Under cystoscopic visualization, the provider performs a diagnostic cystoscopy to inspect the bladder mucosa, ureteric orifices, and urethra. Using the cystoscope, the provider inserts a fine needle transurethrally into the detrusor muscle and injects a neurolytic agent (commonly onabotulinumtoxinA) into multiple sites of the bladder wall to reduce detrusor overactivity. Post-procedure workflow includes monitoring for urinary retention, providing instructions for clean intermittent catheterization if retention occurs, arranging follow-up for symptom assessment and possible post-void residual measurement, and documenting informed consent and injection log (sites and units). Typical site of service is an outpatient procedure room, ambulatory surgical center (ASC), or hospital outpatient department (HOPD) depending on patient comorbidities and payer rules. Typical preauthorization, procedure note, and post-procedure documentation are part of the clinical workflow.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    52000Cystourethroscopy, with or without catheterization; diagnostic, including urethral calibration and/or ureteroscopy when performedPerformed prior to or as part of the evaluation to inspect the bladder and urethra; diagnostic cystoscopy may be documented if done separately.
    52204Cystourethroscopy, with ureteroscopy, with or without biopsy; with removal of foreign body, calculus, or obstructionRelated endoscopic bladder/urethral procedures that may be performed during the same session if indicated.
    53860Complex repair of bladder neck; typically used for open proceduresNot commonly performed with cystoscopic injections but listed for surgical workflow when more invasive bladder surgery is required.
    51701Measurement of post-voiding residual urine and/or bladder capacity, non-invasive, with ultrasoundOften used in follow-up to assess urinary retention after detrusor injection.
    51702Bladder capacity measurement, invasive (urodynamic testing)Urodynamic testing may be done pre-procedure to document detrusor overactivity and guide treatment selection.

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    66Modifier 66 (Surgical Team) is used when three or more surgeons act as primary surgeons on a single, highly complex procedure. The AMA defines it for use when a surgical team — often composed of…- Use modifier 66 when three or more surgeons act as primary surgeons working collaboratively as a surgical team on a single, highly complex or difficult procedure (for example organ…
    73Modifier 73 indicates a facility-level outpatient hospital or ASC procedure that was discontinued after the patient was prepared and taken to the procedure/operating room but before any anesthesia…- When to use: Apply CPT modifier 73 on the FACILITY (outpatient hospital or ASC) claim when the patient has been fully prepared and physically taken into the procedure/operating room but the…
    74Modifier ‑74 indicates an outpatient hospital or ASC procedure that was discontinued after anesthesia was administered and after the procedure had begun. Use this modifier when anesthesia (local,…- Use modifier -74 when a procedure in an outpatient hospital or ASC setting is terminated after anesthesia has been administered and after the procedure has commenced (for example, after incision,…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207RG0100X
    2080P0207X
    207L00000X
    208000000X
    261QM0801X
    2471M2300X
    3416L0300X
    207ZP0213X

    Related Payer Policy Updates

    Specialty: Obstetrics/Gynecology1 / 2

    10 rows

    PolicyPayerEffective Date
    Abortion ServicesNew Mexico Health Care Authority2027-01-01
    Prolonged Services for Labor ManagementPremera Bluecross2027-01-01
    Prolonged Services for Labor ManagementPremera Bluecross2027-01-01
    Abnormal Uterine Bleeding and Uterine FibroidsColorado Rocky Mountain Health Plans2026-11-01
    Obstetrical Home Care ProgramsAmbetter Georgia2026-11-01
    Maternal Serum Testing for Prediction of Adverse Obstetric OutcomesPremera Bluecross2026-10-01
    Maternal Serum Testing for Prediction of Adverse Obstetric OutcomesPremera Bluecross2026-10-01
    Maternal Serum Testing for Prediction of Adverse Obstetric OutcomesBlue Cross Blue Shield - Massachusetts2026-10-01
    Cervical Cancer ScreeningOscar Health2026-10-01
    Prenatal Testing for Fetal AneuploidyOscar Health2026-10-01

    Related Codes

    CPT-52204-CYSTOURETHROSCOPY-WITH-BIOPSY

    CPT 52204: Cystourethroscopy with Biopsy

    CPT-52214-TRANSURETHRAL-BLADDER-URETHRAL-TISSUE-DESTRUCTION

    CPT 52214: Endoscopic Destruction of Bladder/Urethral Tissue

    CPT-52224-CYSTOSCOPY-LESION-DESTRUCTION-MINOR

    CPT 52224: Cystoscopy with Destruction of Minor Bladder Lesion

    CPT-52234-CYSTOSCOPIC-DESTRUCTION-SMALL-BLADDER-LESION

    CPT 52234: Cystoscopy with Destruction of Small Bladder Lesion

    CPT-52235-CYSTOSCOPIC-DESTRUCTION-MEDIUM-BLADDER-LESION-2-5CM

    CPT 52235: Cystoscopy with Fulguration of Medium Bladder Lesion

    CPT-52240-CYSTOSCOPY-LESION-FULGURATION-ABLATION-GREATER-THAN-5CM

    CPT 52240: Cystoscopy with Destruction of Bladder Lesion (>5.0 cm)

    CPT-52250-CYSTOSCOPIC-INTRAVESICAL-RADIOACTIVE-THERAPY-FOR-BLADDER-CANCER

    CPT 52250: Cystoscopy with Intravesical Radioisotope Therapy

    CPT-52260-DIAGNOSTIC-CYSTOSCOPY-INTERSTITIAL-CYSTITIS-EVALUATION

    CPT 52260: Cystoscopic Inspection Under Anesthesia for Interstitial Cystitis

    CPT-52265-DIAGNOSTIC-CYSTOSCOPY-INTERSTITIAL-CYSTITIS-EVALUATION

    CPT 52265: Diagnostic Cystoscopy for Interstitial Cystitis

    CPT-52270-CYSTOSCOPIC-URETHROTOMY-INTERNAL-URETHRAL-STRICTURE

    CPT 52270: Cystoscopy with Incision of Internal Urethral Stricture (Female)

    Showing 1–10 of 26

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.